Biotech

All Articles

Pfizer takes $230M struck after axing fell short DMD genetics treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics therapy breakdown has actually blown a $2...

AC Immune finds 'spots' prospective in Alzheimer's drug information

.After much more than 20 years of focus on neurodegenerative illness, Swiss biotech air conditioning...

GSK goes down ph. 2 HPV vaccination over absence of best-in-class prospective

.GSK has actually broken up a phase 2 individual papillomavirus (HPV) vaccine from its own pipeline ...

OS Therapies refiles $6M IPO to cash HER2 drug, preclinical ADCs

.Operating system Therapies will definitely specify on the NYSE American supply exchange this mornin...

ALX's fizzling CD47 response cost sends out inventory spiraling down

.ALX Oncology's stage 2 gastric cancer feedback price has compromised. After finding its own CD47 bl...

Ionis centers eye disease from aim ats of Roche-partnered possibility after data disappoint

.One More of Ionis Pharmaceuticals' key midphase readouts has actually disappointed requirements, ur...

Biogen's CEO pointed out no unsafe sell 2023. He's ready to be vibrant

.While Biogen's pharma peers are actually hunting for late-stage properties with little bit of dange...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has been a biotech trying to find a pipeline after it junked its own lead possessi...

Biogen leaves Denali Alzheimer's collab

.Biogen has actually returned legal rights to an early Alzheimer's health condition course to Denali...

Takeda taps new head people oncology organization-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of substantial management hirings, firings an...